Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis
- PMID: 16142384
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis
Abstract
Matrix metalloproteinases (MMPs) are associated with invasion and metastasis of several human malignant tumors, in particular MMP-7, which is mainly produced by the cancer cell itself. We examined the expression of MMP-2, 7 and 9, and tissue inhibitors of metalloproteinase (TIMP)-1 and 2 in uterine endometrial carcinoma, and compared the expression with clinicopathological characteristics in uterine endometrial carcinoma (UEC). A group of 256 patients with UEC received surgery at the Osaka City University Medical School Hospital, and 196 tumor samples were immunohistochemically stained to examine the expression of MMP-2, 7 and 9, and TIMP-1 and 2. Additionally, the invasion ability of cell stain established from UEC was examined using an in vitro invasion assay. The expression of MMP-2, 7 and 9, and TIMP-1 and 2 was observed in the cytoplasm, and the expression of MMP-2 and 7, and TIMP-1 and 2 was observed in stromal cells around the tumor cells. The expression of MMP-7 was significantly stronger in higher-grade than lower-grade tumors (P<0.05). The invasion assay showed that the invasion of cells derived from UECs was significantly inhibited by TIMP-1 and 2. The disease-free interval was significantly shorter when MMP-7 expression was intense. This increased expression of MMP-7 in high grade UECs may be associated with tumor invasion and metastasis, and MMP-7 could serve as a prognostic maker in UEC.
Similar articles
-
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].Ai Zheng. 2004 Oct;23(10):1194-8. Ai Zheng. 2004. PMID: 15473934 Chinese.
-
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].Ai Zheng. 2002 Jul;21(7):735-9. Ai Zheng. 2002. PMID: 12479097 Chinese.
-
Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.Clin Cancer Res. 2004 Jul 15;10(14):4746-53. doi: 10.1158/1078-0432.CCR-0625-03. Clin Cancer Res. 2004. PMID: 15269148
-
Matrix metalloproteinases and their inhibitors.Anticancer Res. 1999 Mar-Apr;19(2C):1589-92. Anticancer Res. 1999. PMID: 10365151 Review.
-
Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.Surg Oncol. 2011 Mar;20(1):e18-22. doi: 10.1016/j.suronc.2010.08.004. Epub 2010 Sep 29. Surg Oncol. 2011. PMID: 20880700 Review.
Cited by
-
Chromatin architectural factor CTCF is essential for progesterone-dependent uterine maturation.FASEB J. 2023 Aug;37(8):e23103. doi: 10.1096/fj.202300862R. FASEB J. 2023. PMID: 37489832 Free PMC article.
-
Expression Profiles of Matrix Metalloproteinases and Their Inhibitors in Nasal Polyps.J Inflamm Res. 2024 Jan 3;17:29-39. doi: 10.2147/JIR.S438581. eCollection 2024. J Inflamm Res. 2024. PMID: 38193041 Free PMC article.
-
No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1925-8. doi: 10.1158/1055-9965.EPI-09-0244. Epub 2009 May 12. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19435861 Free PMC article. No abstract available.
-
Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.Fertil Steril. 2009 Jun;91(6):2650-63. doi: 10.1016/j.fertnstert.2008.03.071. Epub 2008 Jul 30. Fertil Steril. 2009. PMID: 18672237 Free PMC article.
-
Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades.Med Oncol. 2011 Dec;28 Suppl 1:S433-8. doi: 10.1007/s12032-010-9660-7. Epub 2010 Aug 31. Med Oncol. 2011. PMID: 20809186
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous